Direkt zum Inhalt

Ortmann, O. ; Pagani, O. ; Jones, A. ; Maass, N. ; Noss, D. ; Rugo, H. ; van de Velde, C. ; Aapro, Matti ; Coleman, R.

Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel

Article

Ortmann, O., Pagani, O., Jones, A., Maass, N., Noss, D., Rugo, H., van de Velde, C., Aapro, Matti and Coleman, R. (2011) Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel. Cancer Treatment Reviews 37 (2), pp. 97-104.



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleCancer Treatment Reviews
PublisherELSEVIER SCI LTD
Place of PublicationOXFORD
Volume37
Number of Issue or Book Chapter2
Page Rangepp. 97-104
Date2011
Date of publication19 Dec 2024 11:13
InstitutionsMedicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde)
Identification Number
ValueType
10.1016/j.ctrv.2010.05.005DOI
KeywordsCHEMOTHERAPY-INDUCED AMENORRHEA; MENOPAUSAL TRANSITION; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; ADJUVANT THERAPY; BONE LOSS; TAMOXIFEN; LETROZOLE; HORMONE; YOUNGER; Adjuvant therapy; Aromatase inhibitors; Breast cancer; Menopause; Perimenopause; Tamoxifen
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID65099

Export bibliographical data

Owner only: item control page

nach oben